vimarsana.com

Page 5 - மறுவடிவமைப்பு செய்யப்பட்டது News Today : Breaking News, Live Updates & Top Stories | Vimarsana

How new Pacific TV series Teine Sā is reimagining ancient legends for a modern audience

How new Pacific TV series Teine Sā is reimagining ancient legends for a modern audience 13 May, 2021 04:00 AM 2 minutes to read Teine Sā - The Ancient Ones trailer. NZ Herald A new TV series has rewritten ancient Pacific legends through a modern lens. New horror series Teine Sā tells the stories of five different female deities and their impact on young Pacific women facing the issues of the modern world - and it s the first time in years that Pacific legends have been brought to life on our screens. Read More Directed by the internationally acclaimed Toa Fraser and Sima Urale, it s also the first TV series to feature a Melanesian story written, directed and crewed by Melanesian women.

Billionaire Kiwi citizen Peter Thiel backs new $13 billion crypto exchange

ReShape Lifesciences Inc : Obalon Therapeutics, Inc Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc

ReShape Lifesciences Inc.: Obalon Therapeutics, Inc. Urges Stockholders to IMMEDIATELY Vote FOR All Proposals Related to the Merger with ReShape Lifesciences Inc IMMEDIATELY vote FOR the proposals put forth in its proxy statement to be voted on at the May 13, 2021 special meeting of stockholders, all of which relate to the proposed merger with ReShape Lifesciences Inc., a global weight-loss solutions company offering an integrated portfolio of proven products and services that manage and treat obesity and associated metabolic disease. We are urging all of our stockholders to take a few minutes to vote by phone or email on this important transaction, said Obalon CEO Andrew Rasdal. The merger with ReShape cannot be completed without the approval of each of the proposals being voted on at the special meeting, including approval of the proposed reverse stock split.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.